sonazoid | Sonazoid™ - International Contrast Ultrasound Society

Keyword	CPC	PCC	Volume	Score	Length of keyword
sonazoid	1.04	1	8073	98	8

Keyword	CPC	PCC	Volume	Score
sonazoid	1.45	0.5	2116	70
sonazoid contrast agent	1.91	0.3	9452	49
sonazoid spc	1.05	0.5	1771	83
sonazoid ge	0.93	0.2	2653	7
sonazoid fda	0.28	0.6	9234	46
sonazoid ge healthcare	0.23	0.3	2635	33
sonazoid microbubble preparation	0.86	1	2628	6

Search Results related to sonazoid on Search Engine

Sonazoid™ - International Contrast Ultrasound Society
icus-society.org

https://icus-society.org/wp-content/uploads/2022/02/Sonazoid-Educational-Deck.pdf

WEBSonazoidTM. Enabling diagnosis of focal liver lesions in vascular-phase imaging and enhanced detection of lesions in Kupffer-phase imaging1. Administration of Sonazoid enables vascular-phase imaging immediately and Kupffer-phase imaging (hepatic parenchymal enhancement) from about 10 minutes after injection1. Reference: 1.

DA: 81 PA: 96 MOZ Rank: 89

A review of contrast-enhanced ultrasound using SonoVue® and Sonazoid
sciencedirect.com

https://www.sciencedirect.com/science/article/pii/S0720048X23003741

WEBOct 1, 2023 · A judicious selection of ultrasound contrast agent (UCA) is imperative for optimizing imaging and improving diagnosis. Approved UCAs for imaging the majority of organs include SonoVue, a pure blood agent, and …

DA: 55 PA: 29 MOZ Rank: 8

GE Healthcare SONAZOIDTM - International Contrast …
icus-society.org

https://icus-society.org/wp-content/uploads/2022/02/Sonazoid-Package-Insert-Singapore_Aug2021.pdf

WEBSonazoid is an ultrasound contrast agent for use in vascular phase and Kupffer phase for ultrasonic imaging of focal hepatic lesions. Posology and method of administration. This medicinal product should always be given by a physician or other qualified health personnel.

DA: 75 PA: 95 MOZ Rank: 86

Physicochemical characteristics of Sonazoid, a new contrast ... - PubMed
nih.gov

https://pubmed.ncbi.nlm.nih.gov/18255220/

WEBIt has been demonstrated that Sonazoid powder for injection consists of microspheres of perfluorobutane (PFB) s … The objective of the current work is to describe the physicochemical characteristics of Sonazoid, a new ultrasound contrast agent for detection and characterisation of focal liver lesions.

DA: 58 PA: 61 MOZ Rank: 87

Ultrasound contrast agent Sonazoid for the diagnosis of hepatic
biomedcentral.com

https://bmcgastroenterol.biomedcentral.com/articles/10.1186/s12876-021-02064-1

WEBDec 20, 2021 · Sonazoid® (perfluorobutane microbubbles), a new contrast agent that facilitates hepatic parenchyma-specific Kupffer phase imaging on contrast-enhanced ultrasonography (CEUS), is useful for the detection and characterization of …

DA: 87 PA: 68 MOZ Rank: 65

The AFSUMB Consensus Statements and Recommendations for …
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315291/

WEBApr 27, 2020 · The new proposed consensus statements and recommendations provide general advice on the use of Sonazoid and are intended to create standard protocols for the use and administration of Sonazoid in hepatic and pancreatobiliary applications in Asian patients and to improve patient management.

DA: 31 PA: 15 MOZ Rank: 50

Sonazoid™ versus SonoVue® for Diagnosing Hepatocellular …
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614293/

WEBSep 30, 2022 · Sonazoid™ versus SonoVue ® for Diagnosing Hepatocellular Carcinoma Using Contrast-Enhanced Ultrasound in At-Risk Individuals: A Prospective, Single-Center, Intraindividual, Noninferiority Study

DA: 38 PA: 55 MOZ Rank: 77

Efficacy of Sonazoid (Perflubutane) for Contrast-Enhanced ... - AJR
ajronline.org

https://www.ajronline.org/doi/full/10.2214/AJR.12.10518

WEBMar 24, 2014 · Sonazoid (perflubutane, Daiichi-Sankyo Pharmaceuticals) is an ultrasound contrast agent that is freeze dried for injection. It consists of perflubutane gas microspheres stabilized by hydrogenated egg–phosphatidylserine membrane [ 1 ].

DA: 6 PA: 74 MOZ Rank: 87

Contrast-enhanced ultrasound | Radiology Reference Article
radiopaedia.org

https://radiopaedia.org/articles/contrast-enhanced-ultrasound-2

WEBSep 25, 2023 · Sonazoid (GE Healthcare) SonoVue/Lumason (Bracco) SonoVue is a purely intravascular contrast agent, therefore it allows assessment of the vascularity and non-specific contrast agent retention of lesions. Due to its widespread approval, it is by far the most commonly utilized ultrasound contrast agent currently.

DA: 61 PA: 74 MOZ Rank: 80

Physicochemical Characteristics of Sonazoid™, A New Contrast …
sciencedirect.com

https://www.sciencedirect.com/science/article/pii/S0301562907005662

WEBMay 1, 2008 · Physicochemical Characteristics of Sonazoid™, A New Contrast Agent for Ultrasound Imaging. Per ChristianSontum. Show more. Add to Mendeley. https://doi.org/10.1016/j.ultrasmedbio.2007.11.006Get rights and content. Abstract.

DA: 58 PA: 64 MOZ Rank: 54